Ensign Peak Advisors’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-24,802
Closed -$311K 1735
2024
Q1
$311K Sell
24,802
-1,251
-5% -$16.2K ﹤0.01% 1690
2023
Q4
$400K Buy
26,053
+4,250
+19% +$59.4K ﹤0.01% 1689
2023
Q3
$320K Hold
21,803
﹤0.01% 1680
2023
Q2
$386K Hold
21,803
﹤0.01% 1683
2023
Q1
$388K Buy
21,803
+2,550
+13% +$47.7K ﹤0.01% 1683
2022
Q4
$377K Buy
19,253
+7,200
+60% +$146K ﹤0.01% 1686
2022
Q3
$230K Hold
12,053
﹤0.01% 1821
2022
Q2
$216K Hold
12,053
﹤0.01% 1771
2022
Q1
$348K Hold
12,053
﹤0.01% 1702
2021
Q4
$334K Sell
12,053
-22,850
-65% -$646K ﹤0.01% 1776
2021
Q3
$945K Hold
34,903
﹤0.01% 1455
2021
Q2
$981K Hold
34,903
﹤0.01% 1443
2021
Q1
$769K Hold
34,903
﹤0.01% 1498
2020
Q4
$652K Hold
34,903
﹤0.01% 1544
2020
Q3
$541K Hold
34,903
﹤0.01% 1512
2020
Q2
$533K Hold
34,903
﹤0.01% 1453
2020
Q1
$445K Hold
34,903
﹤0.01% 1418
2019
Q4
$840K Buy
+34,903
New +$796K ﹤0.01% 1395

Other funds holding TBI

Ensign Peak Advisors's TBI Position: Q2 2024 in Review

Ensign Peak Advisors sold out of Trueblue (TBI) in Q2 2024, closing a stake of 24,802 shares — an estimated $311K sold.

Ensign Peak Advisors first reported a position in TBI in Q4 2019 and held it in 18 quarters. The position peaked at $981K in Q2 2021. 121 funds tracked by Wall St. Rank hold TBI as of Q2 2024.

  • Ensign Peak Advisors reported no remaining Trueblue position as of Q2 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 24,802 Trueblue shares in Q2 2024, an estimated $311K.
  • Ensign Peak Advisors first reported a position in Trueblue in Q4 2019 and held it in 18 quarters.
  • Ensign Peak Advisors's Trueblue position peaked at $981K in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Trueblue as of Q2 2024.

Based on Ensign Peak Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.